Abstract
Background & Aims
Medulloblastoma (MB) is a primary malignant tumor of the brain. They are categorized as WHO grade IV neoplasms, and mostly occur in children. The traditional therapy for MB is surgery, followed by radiation and chemotherapy, but the clinical outcome is still poor and has a high possibility of recurrence. The mechanism underlying the development of MB should be further investigated to develop novel therapeutic strategies.
Methods
Research has demonstrated that circRNAs contribute to tumorigenesis, but the functional mechanism of circRNAs in MB has not been fully explored and remains vague. The differentially expressed circRNAs between MB and normal cerebellar tissues were analyzed based on the microarray expression profiles to characterize the potential mechanism of circRNAs in MB.
Results
The results revealed that circRNA_103128 was highly expressed in MB, and cellular and animal experiments were performed to verify its tumorigenic effect in MB. Furthermore, a bioinformatics analysis and literature review previous literature were performed, confirming miR-129-5p as a target gene downstream of circRNA_103128. In addition, SOX4 was predicted to be a downstream target protein of miR-129-5p. Subsequently, miR-129-5p expression was inhibited, which revealed the regulatory mechanism of circRNA_103128. The latter promotes MB cell growth, migration, and invasion by the sponge effect of miR-129-5p, thereby affecting the expression of SOX4.
Conclusions
This study is the first to systematically demonstrate that circRNA_103128 may play an important regulatory role in MB through a sponge effect with miR-129 -5p, which affects SOX4 expression and regulates tumorigenesis and tumor cell development in MB.
Similar content being viewed by others
Data availability
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
References
Bossi L, Figueroa-Bossi N (2016) Competing endogenous RNAs: a target-centric view of small RNA regulation in bacteria. Nat Rev Microbiol 14(12):775–784
Chen M, Lai X, Wang X, Ying J, Zhang L, Zhou B, Liu X, Zhang J, Wei G, Hua FJFIM (2021) Long non-coding RNAs and circular RNAs: insights into microglia and astrocyte mediated neurological diseases. Front Mol Neurosci 14:745066
Crawford J, MacDonald T, Packer RJTLN (2007) Medulloblastoma in childhood: new biological advances. Lancet Neurol 6(12):1073–1085
de Bont JM, Kros JM, Passier MM, Reddingius RE, Sillevis Smitt PA, Luider TM, den Boer ML, Pieters R (2008) Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro Oncol 10(5):648–660
Esquela-Kerscher A, Slack FJNRC (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6(4):259–269. https://doi.org/10.1038/nrc1840.
Fan D, Zhu Y (2022) Circ_0120175 promotes laryngeal squamous cell carcinoma development through upregulating SLC7A11 by sponging miR-330-3p. J Mol Histol 53(2):159–171
Fesler A, Zhai H, Ju J (2014) miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer. Onco Targets Ther 7:1481–1485
Gao G, Xiu D, Yang B, Sun D, Wei X, Ding Y, Ma Y, Wang Z (2019) miR-129-5p inhibits prostate cancer proliferation via targeting ETV1. Onco Targets Ther 12:3531–3544
Han J, Zhao G, Ma X, Dong Q, Zhang H, Wang Y, Cui JJB (2018) CircRNA circ-BANP-mediated miR-503/LARP1 signaling contributes to lung cancer progression. Biochem Biophys Res Commun 503(4):2429–2435
Kamachi Y, Uchikawa M, Kondoh H (2000) Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet 16(4):182–187
Kristensen L, Hansen T, Venø M, Kjems JJO (2018) Circular RNAs in cancer: opportunities and challenges in the field. Oncogene 37(5):555–565
Kristensen L, Andersen M, Stagsted L, Ebbesen K, Hansen T, Kjems JJNRG (2019) The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet 20(11):675–691
Li G, Xie J, Wang J (2019) Tumor suppressor function of miR-129-5p in lung cancer. Oncol Lett 17(6):5777–5783
Liu P, Ramachandran S, Ali Seyed M, Scharer CD, Laycock N, Dalton WB, Williams H, Karanam S, Datta MW, Jaye DL, Moreno CS (2006) Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res 66(8):4011–4019
Liu Y, Hei Y, Shu Q, Dong J, Gao Y, Fu H, Zheng X, Yang G (2012) VCP/p97, downregulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma. PLoS ONE 7(4):e35800
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues Paul (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 114(2), 97-109. https://doi.org/10.1007/s00401-007-0243-4 .
Lv T, Miao YF, Jin K, Han S, Xu TQ, Qiu ZL, Zhang XH (2018) Dysregulated circular RNAs in medulloblastoma regulate proliferation and growth of tumor cells via host genes. Cancer Med 7(12):6147–6157
Mao W, Wang K, Xu B, Zhang H, Sun S, Hu Q, Zhang L, Liu C, Chen S, Wu J, Chen M, Li W, Peng BJMC (2021) ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma. Mole Cancer 20(1):142
Mo M, Liu B, Luo Y, Tan JHJ, Zeng X, Zeng X, Huang D, Li C, Liu S, Qiu X (2022) Construction and comprehensive analysis of a circRNA–miRNA–mRNA regulatory network to reveal the pathogenesis of hepatocellular carcinoma. Front Mol Biosci 9:801478
Ostrom Q, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JJN-O (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. BMC Cancer 21:v1–v100
Pollack I, Agnihotri S, Broniscer AJJONP (2019) Childhood brain tumors: current management, biological insights, and future directions. J Neurosurg Pediatr 23(3):261–273
Qin Y, Zhao W, Cheng L, Wu S, Wu Q, Gao J, Bian Z, Ma L (2019) Clinical significance of vasculogenic mimicry, vascular endothelial cadherin and SOX4 in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 12(7):2462–2473
Schepers GE, Teasdale RD, Koopman P (2002) Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev Cell 3(2):167–170
Shi T, Zhang C, Xia S (2022) The potential roles and mechanisms of non-coding RNAs in cancer anoikis resistance. Mol Cell Biochem 477(5):1371–1380
Tang X, Tang J, Liu X, Zeng L, Cheng C, Luo Y, Li L, Qin SL, Sang Y, Deng LM, Lv XB (2016) Downregulation of miR-129-2 by promoter hypermethylation regulates breast cancer cell proliferation and apoptosis. Oncol Rep 35(5):2963–2969
Tiwari N, Tiwari VK, Waldmeier L, Balwierz PJ, Arnold P, Pachkov M, Meyer-Schaller N, Schübeler D, van Nimwegen E, Christofori G (2013) Sox4 is a master regulator of epithelial–mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming. Cancer Cell 23(6):768–783
Wang B, Li Y, Tan F, Xiao Z (2016) Increased expression of SOX4 is associated with colorectal cancer progression. Tumour Biol 37(7):9131–9137
Wang S, Chen Y, Yu X, Lu Y, Wang H, Wu F, Teng L (2019) miR-129-5p attenuates cell proliferation and epithelial–mesenchymal transition via HMGB1 in gastric cancer. Pathol Res Pract 215(4):676–682
Wang X, Xu D, Pei X, Zhang Y, Zhang Y, Gu Y, Li Y (2020) CircSKA3 modulates FOXM1 to facilitate cell proliferation, migration, and invasion while confine apoptosis in medulloblastoma via miR-383-5p. Cancer Manag Res 12:13415–13426
Wei Y, Chen X, Liang C, Ling Y, Yang X, Ye X, Zhang H, Yang P, Cui X, Ren Y, Xin X, Li H, Wang R, Wang W, Jiang F, Liu S, Ding J, Zhang B, Li L, Wang HJH (2020) A noncoding regulatory RNAs network driven by Circ-CDYL acts specifically in the early stages hepatocellular carcinoma. Hepatology 71(1):130–147
Winter J, Jung S, Keller S, Gregory R, Diederichs SJNCB (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 113(3):228–234
Zhang P, Li J, Song Y, Wang X (2017) MiR-129-5p inhibits proliferation and invasion of chondrosarcoma cells by regulating SOX4/Wnt/β-catenin signaling pathway. Cell Physiol Biochem 42(1):242–253
Zhao X, Guan J, Luo M (2021) Circ-SKA3 upregulates ID3 expression by decoying miR-326 to accelerate the development of medulloblastoma. J Clin Neurosci 86:87–96
Zheng Y, Zhang J, Ye B (2020) miR-138 mediates sorafenib-induced cell survival and is associated with poor prognosis in cholangiocarcinoma cells. Clin Exp Pharmacol Physiol 47(3):459–465
Acknowledgements
We thank all members of the Key Laboratory of Neurology of Gansu Province, the Department of Neurosurgery of Lanzhou University Second Hospital.
Funding
Funding was supported by Natural Science Foundation of Gansu Province (18JR3RA365, 2021RCXM096, 21JR7RA420, 21JR7RA426, 20JR10RA758), Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital (CY2022-QN-B05), National Natural Science Foundation of China (81960541, 82060455), Lanzhou Science and Technology Bureau (2018-1-109).
Author information
Authors and Affiliations
Contributions
YP and GY conceived the study and carried out its design. HY, YZ, XH, and QL performed the experiments. QD, YL, XW conducted the statistical analyses. HY wrote the paper; GY and YP revised the paper. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Hang Yin, Yingnan Zhao and Yang Liu contributed equally to this work.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yin, H., Zhao, Y., Han, X. et al. Circ_103128 is associated with the tumorigenesis of medulloblastoma. J Cancer Res Clin Oncol 149, 11339–11349 (2023). https://doi.org/10.1007/s00432-023-04999-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-023-04999-2